Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bioequivalence of Dong-A Atorvastatin vs Lipitor in Healthy Volunteers
NCT04325009Phase 1Unknown
- Sponsor
- Dong-A ST
- Start
- Mar 2020
- Primary completion
- May 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised, open-label trial of atorvastatin in hypercholesterolemia (2 arms), sponsored by Dong-A ST. Primary endpoints: Area Under the plasma Concentration versus time curve at 36 hours and Peak Plasma Concentration at 36 hours. Status: unknown.
02
Drugs
atorvastatin
03
Conditions
hypercholesterolemia
Beyond the preview
Go deeper on NCT04325009.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04325009.